EWM
concept 117 sources

Medical Experimentation on Human Subjects

western-medicine american-medicine public-health
Eras colonial, early-nineteenth-century, late-nineteenth-century, early-twentieth-century, twentieth-century, contemporary
First appearance colonial era; systematized 19th century

Medical Experimentation on Human Subjects

Summary

The history of medical experimentation on human subjects in the Western tradition, and particularly in the United States, reveals a persistent structural pattern: the people who bore the pain and risk of experimental medicine were overwhelmingly those with the least power to refuse. Enslaved people, prisoners, the poor, the institutionalized, and racial minorities served as the primary material for research whose benefits accrued to populations that did not share the risk. The ethical regulatory framework that now governs human subjects research (the Nuremberg Code, the Belmont Report, the IRB system) was constructed not proactively but reactively, in response to abuses that had already occurred and could no longer be concealed. This page focuses on the social history of who was experimented upon and why; for the intellectual history of experimental methodology, see experimental-medicine.

The Antebellum Experimental Economy

Enslaved Bodies as Experimental Material

Slave-owning physicians bought and hired slaves on whom to conduct experiments too painful, too risky, or otherwise too objectionable to inflict upon whites.(Washington, Harriet A., 2006) Half the original articles in the 1836 Southern Medical and Surgical Journal involved experiments on Black subjects; experiments on slaves were conducted in slave quarters, backyard shacks designated as “slave hospitals,” and clinic wards without any organized oversight or consent mechanism.(Washington, Harriet A., 2006)

The experimental practices documented by Washington range across the full spectrum of antebellum medical practice. Dr. Thomas Hamilton of Georgia conducted heat-stroke experiments on enslaved man John Brown, repeatedly poaching him to the point of fainting and blistering his skin, then marketed the results as a patent medicine.(Washington, Harriet A., 2006) Dr. Walter F. Jones of Petersburg, Virginia, in 1846 experimented by pouring boiling water on naked enslaved typhoid pneumonia patients at four-hour intervals.(Washington, Harriet A., 2006) Crawford Long used an enslaved Black boy’s involuntary ether inhalation as evidence that ether was safe for anesthesia, then tested it formally on three enslaved people before using it on white patients.(Washington, Harriet A., 2006) Thomas Jefferson vaccinated two hundred slaves against smallpox with a questionable vaccine before vaccinating his white family.(Washington, Harriet A., 2006)

Sims and the Gynecological Experiments

James Marion Sims conducted over thirty unanesthetized surgeries on enslaved woman Anarcha alone, perfecting the vesicovaginal fistula repair, then performed the same procedure on white women with full anesthesia, contradicting his claim that the procedure was not painful enough to justify anesthetic.(Washington, Harriet A., 2006) Sims addicted the enslaved women to morphine, administering it only after surgery to control post-operative behavior rather than to alleviate the pain of the procedure itself; the addiction weakened their will to resist repeated operations.(Washington, Harriet A., 2006) Sims’s colleague Bozeman later asserted that “not one half” of the slave women they operated on together received any relief from years of painful surgeries — a direct contradiction of the claim that their suffering was justified by medical benefit.(Washington, Harriet A., 2006) Sims physically restrained enslaved man Sam with straps and performed a forty-minute unanesthetized jaw surgery before medical students, noting that the innovation had “proved its practicality…whether the patient is willing or not.”(Washington, Harriet A., 2006) Washington frames this as a violation of distributive justice: the most powerless captive group bore the pain and risk while a privileged group enjoyed the medical benefits, a pattern that persists into the present.(Washington, Harriet A., 2006)

Cooper Owens’s Medical Bondage extends the Sims case into a fuller account of the antebellum experimental economy in gynecology. The first women’s hospital in the United States was housed on a small slave farm in Mount Meigs, Alabama, where between 1844 and 1849 Sims operated on Anarcha, Betsy, Lucy, and roughly nine other unidentified enslaved women.(Cooper Owens, Deirdre, 2017) Sims’s first three vesicovaginal fistula patients were Anarcha — a seventeen-year-old whose fistula had developed during her protracted labor under Sims’s own care — plus Betsy and Lucy, both leased from their owners.(Cooper Owens, Deirdre, 2017) Sims’s white medical apprentices, including Nathan Bozeman, quit after two years of unsuccessful surgeries; Sims then trained the enslaved patients themselves to work as surgical nurses while they continued their domestic and agricultural labor, so that during their five years on his farm they came to know more about the repair of obstetric fistulae than most American physicians.(Cooper Owens, Deirdre, 2017)(Cooper Owens, Deirdre, 2017) After thirty surgeries on Anarcha, Sims successfully closed her fistula with silver sutures (an improvement on John Peter Mettauer’s lead sutures) and then repeated the technique on the other patients.(Cooper Owens, Deirdre, 2017) When Sims left the South for New York, he sold the Alabama women’s hospital to Bozeman, his former assistant and a fellow slave owner, who continued operating it on a primarily enslaved population.(Cooper Owens, Deirdre, 2017)

The full antebellum sweep of experimental gynecology is wider still. Mettauer himself had performed repeated experimental fistula surgeries on a twenty-year-old enslaved woman over four years, blaming his failures on her continued sexual activity, which she had little power to refuse.(Cooper Owens, Deirdre, 2017) In April 1850 in Augusta, Georgia, Dr. Paul Eve assembled a surgical team that performed what they claimed was the first successful full uterine removal in the United States on Mary, a twenty-eight-year-old married enslaved woman; Mary died three months later.(Cooper Owens, Deirdre, 2017) In 1819 in Columbia, South Carolina, Dr. Charles Atkins performed a series of emergency surgeries on Nanny, an enslaved woman whose stillborn twins he removed by hand and surgical blade over two days, despite warnings from her plantation community that her body was “too delicate” to bear children.(Cooper Owens, Deirdre, 2017) Cooper Owens documents the patterns by which Sims’s experimental work generated downstream demand: after his 1852 article on vesicovaginal fistulae appeared in the American Journal of Medical Sciences, the journal’s publication of articles on sexual surgeries on women increased by more than 100 percent.(Cooper Owens, Deirdre, 2017)

After Ephraim McDowell’s 1809 ovariotomy on Jane Todd Crawford, McDowell continued experimental surgical work almost exclusively on Black women, finding four enslaved women with ovarian tumors in the Danville area to operate on over nearly a decade.(Cooper Owens, Deirdre, 2017) An 1835 ovariotomy in Charleston required four doctors and two medical students to physically restrain a thirty-five-year-old enslaved woman who “screamed and struggled violently”; she never again menstruated after the procedure (probably rendered sterile by it, decreasing her economic value), and her excised ovary was displayed in the Medical College museum.(Cooper Owens, Deirdre, 2017) Cooper Owens emphasizes the silent counter-evidence such cases supplied: physicians described in their writings how and why they restrained enslaved women during childbirth and surgery, a practice that would have been unnecessary if Black women were impervious to pain as the racial science claimed.(Cooper Owens, Deirdre, 2017) An 1850 census recorded a one-year-old mulatto girl on Sims’s slave farm born to one of his enslaved gynecological patients, raising questions about paternity and ethics that Cooper Owens, applying historical and cultural reasoning, suspected even before locating the document.(Cooper Owens, Deirdre, 2017) At Sims’s 1883 funeral, Dr. William Waring Johnston eulogized the enslaved patients as “humble negro servitors” who had brought “their willing sufferings and patient endurance” to Sims’s research, framing them as voluntary participants when they had no capacity to consent. Yet in Sims’s own autobiography Lucy’s bladder had become inflamed postsurgery, and her “agony was extreme” — testimony that contradicts the eulogist’s claim of willingness.(Cooper Owens, Deirdre, 2017)(Cooper Owens, Deirdre, 2017) An 1862 illustration of Sims operating on a fistula patient sanitized the historical record by depicting a fully-clothed white patient with a white nurse handling the speculum, erasing the naked, restrained enslaved women on whom the original procedures were actually performed.(Cooper Owens, Deirdre, 2017)

Beaumont’s 1833 Ethical Framework

Antebellum medicine did not lack an articulated ethics of human experimentation; it failed to apply one. In 1833, the same decade Sims began his experiments, William Beaumont set out a written framework for nontherapeutic research on human subjects that included recognition that “voluntary consent of the subject is necessary,” that experiments should be discontinued when they cause distress, and that “the project must be abandoned when the subject becomes dissatisfied.”(Cooper Owens, Deirdre, 2017) Beaumont’s framework was contemporaneous with the slave-farm experiments and prefigured by more than a century the consent provisions of the Nuremberg Code; the antebellum failure to apply such standards to enslaved patients was therefore not a matter of unavailable ethical concepts but of the deliberate exclusion of Black patients from the moral category to which the concepts applied. Sims himself violated the AMA Code of Ethics’ prohibition on abandoning incurable patients when, according to his protégé Thomas Addis Emmet, he abandoned his Irish-born patient Mary Smith after botching her final surgery.(Cooper Owens, Deirdre, 2017)

Conjure, Insurrection, and the Threat of Black Medical Authority

The association between enslaved medical knowledge and political threat went beyond the individual poisoning case. Male conjure doctors were connected to organized insurrectionary threats: during the American Revolution a conjurer known as Ben gathered a group of enslaved people to join the British in Virginia; in the 1822 Denmark Vesey conspiracy in Charleston, Gullah Jack Pritchard — described at trial as “a conjurer and a physician, in his own country” — promised protection from harm to Vesey’s followers and served as a military leader. The Goomer case in a 1812 North Carolina conspiracy followed the same pattern.(Fett, Sharla M., 2002) Slaveholders recognized that a healer’s authority over a community and mobility across plantation boundaries could function as an organizing infrastructure; this is why the fear of Black healers was never purely medical. The anxiety about poisoning and the anxiety about insurrection were, for slaveholders, the same anxiety.

Feigning, Detection, and the Physician as Labor Enforcer

The feigning problem brought physicians into the apparatus of plantation labor discipline. Planters responded to suspected feigning with a range from resigned accommodation to violent coercion: at the least severe, slaveholders dismissed enslaved illness claims; at the most severe, they used whipping to drive enslaved people back to work, following instructions like those Nathaniel Hooe wrote his son-in-law about an enslaved woman who “counterfeited” sickness: “to make her perform have to be tight with her.”(Fett, Sharla M., 2002) Physicians were drawn into this system through career incentives. M. L. McLoud’s 1850 medical thesis advised that a physician’s ability to expose “imposture” would build planter confidence and advance the doctor’s career, explicitly prioritizing the planter client’s trust over the enslaved patient’s.(Fett, Sharla M., 2002)

Some physicians went further and used medicines punitively, deploying emetics, purgatives, and foul-tasting preparations both to detect and deter feigning, blurring the line between treatment and torture. McLoud approvingly described a neighbor’s physician recommending the whip to “cure” stubborness in a man suspected of feigning an injury, and in another case a physician treating an enslaved woman’s epileptic fits recommended that her next seizure be “treated” with a “cowskin or hickory switch to scourge her on the spine.”(Fett, Sharla M., 2002) This punitive medicalization of surveillance was not Cartwright-level theory; it was routine clinical advice embedded in medical theses circulated among aspiring plantation physicians.

The ideological framework that made this possible rested on a class- and race-coded concept of illness. By the early nineteenth century, “hypochondria” had been named as a disease — but it was a disease reserved for privileged whites in sedentary or studious occupations. Slaveholders rarely attributed hypochondriacal tendencies to enslaved people; the identical behavior — claiming illness without verifiable physical cause — was classified not as a recognizable illness category but as deliberate deception, meaning the leisure to be respectably sick was a white elite prerogative, while the same symptoms in an enslaved person were criminalized rather than pathologized.(Fett, Sharla M., 2002) The contrast marks a clear line in antebellum medicine between whom the diagnostic vocabulary served and whom it policed.

The Irish Parallel and the Continuity to Living Medicine

Mary Smith was the first patient admitted to Sims’s New York Woman’s Hospital in 1855. An Irish immigrant from western Ireland, the country’s poorest region, she arrived as a single mother. Sims and Thomas Addis Emmet performed thirty surgeries on her over six years; Sims then botched a final bladder-stone surgery that destroyed Emmet’s earlier repair, abandoned her, and never published her case. She died two years later as a “common street beggar” near the Woman’s Hospital.(Cooper Owens, Deirdre, 2017)(Cooper Owens, Deirdre, 2017) Cooper Owens reads Smith’s case alongside that of Mary Donovan, an Irish patient with a spinal deformity whom Dr. George Elliot subjected to a water-douche induction at Bellevue Hospital in 1857; her stillborn delivery was published in the New York Medical Journal as a teaching case.(Cooper Owens, Deirdre, 2017) In 1840 Pennsylvania, Dr. George T. Dexter treated an eighteen-year-old Irish girl’s hiccups with manual clitoral stimulation for nearly four months, publishing “Singular Case of Hiccough Caused by Masturbation” in a leading medical journal; Cooper Owens reads the case as evidence that Irish women’s sexual lives, like Black women’s, could be discussed bluntly and indiscriminately in print.(Cooper Owens, Deirdre, 2017)

Cooper Owens connects this antebellum experimental economy directly to ongoing patterns. In October 2015, undergoing in vitro fertilization, she was given two cervical dilations without anesthesia or numbing shot, the doctor describing the expected pain as merely “cramping” though it produced what she calls the worst physical agony of her life.(Cooper Owens, Deirdre, 2017) Studies, she notes, document that Black women suffer chronic pain at higher rates than other Americans while having less access to pain-relief medicines; the historical superbody trope that licensed Sims’s surgeries continues to license the under-treatment of Black women’s pain in twenty-first-century gynecology.(Cooper Owens, Deirdre, 2017) An 1831 case Cooper Owens recovers from the Charleston Medical Journal — Dr. R. S. Bailey’s treatment of an enslaved girl who had been raped so violently she could not urinate for a week — illustrates the fuller continuity: antebellum medical journals could pathologize Black women’s rape and make their physical suffering visible at the very moment when southern courts refused to recognize the crime; medicine was thus a site where, as Cooper Owens phrases it, “race was made,” and what was made there persists.(Cooper Owens, Deirdre, 2017)(Cooper Owens, Deirdre, 2017)

The Surgical Theater and Clinical Display

Southern medical schools advertised the availability of Black “clinical material” as a selling point to prospective students.(Washington, Harriet A., 2006) Dr. T. Stillman in 1838 advertised in the Charleston Mercury for “Fifty Negroes” (sick and “incurable” slaves their owners wished to dispose of) to experiment upon in his infirmary.(Washington, Harriet A., 2006) A surgeon who amputated a slave’s leg purely to demonstrate the procedure to students, with no clinical indication, was censured as a “heartless monster” by a medical journal editor, yet neither the surgeon’s nor the school’s name was published.(Washington, Harriet A., 2006) A Black South Carolina youth underwent anesthesia for a minor genital injury repair; the attending surgeon then removed his testicle without informing him; the boy did not learn of his loss for a week. The surgeon published the case.(Washington, Harriet A., 2006) The degrading clinical display of Black patients blunted physicians’ initial compassion: a medical student who felt sympathy for a Black girl dissection subject recorded a year later that he had delighted in frightening white women with “a piece of dead nigar” from the dissecting table, documenting how professional immersion in racial clinical display eroded the moral sense.(Washington, Harriet A., 2006)

The Anatomical Supply Chain

In 1989, construction workers at the former Medical College of Georgia uncovered nearly 10,000 human bones in the basement, 75 percent of which were Black while Black people comprised 42 percent of the local population.(Washington, Harriet A., 2006) Grandison Harris, an enslaved man purchased by the Medical College of Georgia for $700 in 1852, was trained to read obituaries so he could rob Black graves by night; after emancipation he became a Reconstruction judge, then returned to grave robbing for the same institution when Black political power was suppressed.(Washington, Harriet A., 2006) The oral tradition of “night doctors” who stole Black bodies was validated by this discovery; Harris had named Cedar Grove Cemetery as his milieu in a 1908 lecture to students.(Washington, Harriet A., 2006) The 1991 excavation of a colonial-era Negros Burying Ground in Manhattan recovered 427 skeletons showing widespread anatomists’ marks and missing coffins; forensic analysis found no syphilitic bone ridges, contradicting the common medical characterization of Blacks as syphilitic that had helped rationalize their use as dissection subjects.(Washington, Harriet A., 2006) When the grave of Addie Mae Collins — killed in the 1963 Birmingham church bombing — was opened in 1998, it was empty; like untold thousands buried in Black Southern cemeteries, her body had been taken.(Washington, Harriet A., 2006) Even in recent decades the pattern persisted: in 1977 a retired auto mechanic named Casper Yeagin died in Howard University Hospital as an unidentified patient and was on the verge of dissection by medical students when fingerprints identified him; his family had searched for more than two months while hospital staff denied he had been admitted.(Washington, Harriet A., 2006)

Twentieth-Century Programs

Radiation Experiments

Ebb Cade, a Black truck driver recovering from injuries at an Oak Ridge military hospital in 1945, was injected with plutonium-239 without consent, at forty-one times the normal lifetime exposure, before his broken bones were set.(Washington, Harriet A., 2006) Elmer Allen, a Black Pullman porter, was injected with plutonium-238 at UCSF in 1947 under the guise of cancer therapy; his leg was amputated three days later and studied for radioactivity levels over subsequent decades.(Washington, Harriet A., 2006) AEC scientists suppressed the word “plutonium” in all public communications; a 1972 Argonne National Laboratory memo formally banned the term, replacing it with “product” or “49” in what amounted to an institutionalized vocabulary of concealment.(Washington, Harriet A., 2006) AEC physician Joseph Hamilton warned in 1950 that these secret radiation experiments on unwitting subjects violated the Nuremberg Code and would have “a little of the Buchenwald touch” if exposed publicly.(Washington, Harriet A., 2006) The warning was made plausible by the direct import of Nazi scientific personnel: Operation Paperclip brought some seven hundred German scientists to American hospitals and research institutions after World War II, and former Nazi physiologist Herbert Gerstner supervised a total body irradiation project on 263 cancer patients at M.D. Anderson Hospital in Houston between 1951 and 1956, destroying bone marrow and resulting in fatal anemia.(Washington, Harriet A., 2006)

Between 1960 and 1972, University of Cincinnati radiologist Eugene Saenger irradiated 200 cancer patients, 150 of whom were Black; 42 percent of those given higher doses died within weeks, and subjects were told the radiation was therapy.(Washington, Harriet A., 2006) Between 1949 and 1960, the Medical College of Virginia deliberately caused third-degree radiation burns to Black patients — including children at Dooley Hospital and adults at St. Philip Hospital — to study racial differences in radiation damage, yielding one hundred Black subjects per year across a range from six months to ninety years of age.(Washington, Harriet A., 2006) A subject advocate estimated that three of every five radiation experiment victims were people of color.(Washington, Harriet A., 2006)

Prison Experiments

Dr. Albert Kligman conducted pharmaceutical experiments on Holmesburg Prison inmates from 1951 onward, testing 153 drugs between 1962 and 1966, affecting 75 percent of the inmate population, while boasting that “informed consent was unheard of” and “no one asked me what I was doing.”(Washington, Harriet A., 2006) Jesse Williams, a Holmesburg inmate, testified to experiments including radiation burns, sulfuric acid applied to his scrotum, keloid induction, and psychotropic drugs whose behavioral effects persisted permanently.(Washington, Harriet A., 2006) Chester Southam injected 396 Ohio State Prison inmates, more than 180 of them Black, with live cancer cells without disclosing what the cells were, telling them only that it was a “test of immunity.”(Washington, Harriet A., 2006) The CIA’s MK-ULTRA program conducted psychoactive drug experiments at Holmesburg Prison in the 1960s and 1970s; some Black prisoners reported permanent behavioral changes they attributed to these experiments.(Washington, Harriet A., 2006)

African Americans constituted 40 to 61 percent of prison populations in the states where most prison research was conducted; by 2004 they were 44 to 46 percent of all U.S. prisoners, roughly four times their share of the general population.(Washington, Harriet A., 2006) The 1975 ACHRE data showed Black inmates constituted 31 percent of prison research subjects while comprising 68 percent of the general prison population — still three times their national share — indicating selection mechanisms targeting the most vulnerable within the already-confined group.(Washington, Harriet A., 2006) California Medical Facility researchers forcibly administered succinylcholine — a paralytic drug causing the sensation of suffocation — to prisoners without consent in 1967–1968 as aversive conditioning; a federal court ruled this did not violate constitutional rights.(Washington, Harriet A., 2006) The pharmaceutical industry preferred prison subjects because they could be monitored continuously, cost less than free subjects, and, unlike free research subjects, could not leave if they suffered adverse effects or changed their minds; the industry lobbied strenuously to preserve prison research against reform.(Washington, Harriet A., 2006) After the 1976 National Commission ban, prison research underwent a resurgence driven by HIV/AIDS and hepatitis C, with pharmaceutical companies and the NIH pressing for loosened restrictions on incarcerated subjects.(Washington, Harriet A., 2006) After U.S. reforms curtailed domestic prison research, researchers conducted similar experiments in developing countries where regulations were weaker, reproducing the domestic pattern of targeting populations least able to refuse or seek redress.(Washington, Harriet A., 2006)

International Exploitation

The pattern of exploiting vulnerable populations extended beyond U.S. borders. Short-course AZT trials conducted in Africa and Asia in the 1990s used placebo controls despite an established effective standard of care; the trials were approved by U.S. institutions but would not have been permissible on American soil, a double standard compared by Peter Lurie and Sidney Wolfe to the Tuskegee syphilis study.(Washington, Harriet A., 2006) Pfizer’s Trovan antibiotic trial during the 1996 meningitis epidemic in Kano, Nigeria enrolled children without adequate informed consent, allegedly offering the experimental drug in lieu of established therapy; eleven children died and others suffered permanent harm.(Washington, Harriet A., 2006) A flawed 1980s VA study purporting to show that AZT was less effective for Black AIDS patients was used to justify differential treatment for years before its methodological errors were identified, meaning Black patients were denied the first effective AIDS therapy based on unsound research.(Washington, Harriet A., 2006) Multidrug-resistant TB disproportionately affected Black Americans partly because detention policies jailed non-compliant patients rather than providing case-management support; jails with crowded, poorly ventilated conditions then became TB transmission amplifiers, creating a feedback loop that worsened outcomes for Black communities.(Washington, Harriet A., 2006) The AIDSVAX HIV vaccine trial enrolled large numbers of Black and minority subjects, then was abandoned after showing no efficacy; critics charged the trial population had been assembled on the basis of vulnerability rather than likelihood of benefit.(Washington, Harriet A., 2006)

Since the 1990s, Africa has become a primary site for pharmaceutical clinical trials because regulatory requirements are weaker, populations are naive to many drug classes, research costs are lower, and IRB oversight is minimal. Washington characterizes this shift as a new form of medical colonialism that reproduces, on a global scale, the domestic pattern of exploiting populations with the least power to advocate for themselves as research subjects.(Washington, Harriet A., 2006) The Pfizer Trovan trial in Nigeria in 1996 illustrates the consequences: conducted during a meningitis epidemic, it was alleged by Nigerian plaintiffs and the Nigerian government to have administered an untested antibiotic in lieu of established therapy, with backdated consent forms and a forged IRB approval letter, allegations supported by a leaked Pfizer internal document obtained by the Washington Post.(Washington, Harriet A., 2006)

Pediatric and Adolescent Subjects

Children, particularly children of color in institutional settings, constitute a recurring and structurally vulnerable experimental population. Their participation in research depended on the consent of adults whose interests frequently diverged from the child’s, and their inability to refuse created conditions that researchers and institutions consistently exploited.

Between 1956 and 1961, researchers at the Willowbrook State School for children with intellectual disabilities deliberately infected children with hepatitis virus and fed them hepatitis-laced feces to study the disease’s progression. Researchers defended this practice by arguing that children at the institution would probably become infected under any circumstances given institutional conditions, a justification that treated confinement itself as grounds for withdrawal of the child’s right to be free from deliberate harm.(Washington, Harriet A., 2006)

In 1992, the New York State Psychiatric Institute enrolled thirty-four Black and Latino boys between the ages of six and ten in a fenfluramine study designed to test the “violence gene” hypothesis. Fenfluramine carried known cardiac risks and was associated with aggressive behavior; the parents of the boys were not told that the study’s actual purpose was to investigate a genetic basis for violence.(Washington, Harriet A., 2006) The study was one manifestation of a broader federally funded program: in 1992, NIMH director Frederick Goodwin proposed targeting inner-city youth for biological screening to identify individuals predisposed to violence, having equated the behavior of urban African American communities with that of hyperaggressive primates. The resulting “violence initiative” received public funding before congressional outcry forced its cancellation.(Washington, Harriet A., 2006)

Similar assumptions shaped earlier research on XYY males. Studies conducted from the 1960s through the 1970s, based on the hypothesis that males carrying an extra Y chromosome were predisposed to violent behavior, disproportionately enrolled children of color. The hypothesis was ultimately refuted, but not before it had shaped discriminatory institutional policies and permanently stigmatized boys who had been identified as XYY.(Washington, Harriet A., 2006)

Psychosurgery was proposed as a solution to Black urban violence even earlier. Vernon Mark and Frank Ervin’s 1967 book Violence and the Brain proposed surgical intervention for what they characterized as “brain disease” underlying urban riots. Their program targeting Black men perceived as violent received federal NIMH funding before public protests forced its cancellation, demonstrating the ease with which racial threat perception could be transmuted into a medical research agenda with federal support.(Washington, Harriet A., 2006)

From 1989 to 1991, the CDC administered the experimental high-dose Edmonston-Zagreb measles vaccine to approximately 1,500 Black and Latino infants in Los Angeles without informing their parents the vaccine was experimental. The vaccine was subsequently linked to increased mortality among girls in African studies and was never licensed in the United States.(Washington, Harriet A., 2006)

Kennedy Krieger Institute enrolled Black Baltimore families in a lead paint abatement study in the 1990s in which homes were intentionally left with varying degrees of lead contamination without the families’ knowledge. When the study became public, the Maryland Court of Appeals compared it to the Tuskegee syphilis experiments and to Nazi research on concentration camp inmates, a judicial comparison that underscored how the logic of earlier experimental programs had persisted into the late twentieth century.(Washington, Harriet A., 2006)

In the 1990s, pharmaceutical companies routinely enrolled foster children in trials of psychiatric medications, including antipsychotics and antidepressants not approved for pediatric use. Foster children are a disproportionately Black and Latino population; consent was obtained not from parents or guardians but from state social workers, raising fundamental questions about the voluntariness such consent could provide.(Washington, Harriet A., 2006)

Sickle-cell screening programs launched after 1970 demonstrate that well-intentioned genetic programs can inflict population-level harm through structural failure rather than malicious intent. The programs lacked adequate genetic counseling infrastructure; fourteen states passed laws mandating testing for Black Americans only. Carriers were denied employment, rejected from military service, and refused insurance coverage on the false premise that trait status was equivalent to having the disease, producing widespread discrimination without clinical benefit to the communities the programs claimed to serve.(Washington, Harriet A., 2006)

Pharmaceutical and Biomedical Device Testing

The mid-to-late twentieth century produced a distinct experimental pattern: Black patients were enrolled in disproportionate numbers during the risky early phases of pharmaceutical and device development, then excluded from routine clinical benefit once technologies were established. Washington identifies this as a recurring “first Black, then white” dynamic.

Henrietta Lacks, a Black woman, had cancer cells taken without her consent at Johns Hopkins in 1951. Those cells became the HeLa cell line, which has been used in billions of dollars of medical research worldwide. Her family received no compensation and remained unaware her cells were being commercially distributed for decades after her death.(Washington, Harriet A., 2006) The case has since become a central reference point in bioethics discussions of cell line ownership and the commodification of biological material, though the structural conditions that made Lacks’s non-consensual contribution possible have changed less than the legal vocabulary surrounding them.

The AbioCor artificial heart was implanted in Robert Tools, a Black man, in 2001; four of the first seven AbioCor recipients were Black, despite the fact that clinical heart disease research and cardiac surgery had historically excluded Black patients from participation. Washington argues that this pattern is neither accidental nor an overcompensation, but the recurrence of a logic in which Black patients absorb experimental risk while white patients receive the proven benefits after the device is established.(Washington, Harriet A., 2006)

The same structural asymmetry appears in cardiac device policy. Pacemakers and implantable cardiac defibrillators were tested heavily on Black patients in early trials, then prescribed at significantly lower rates to Black cardiac patients after approval, consistent with the pattern Washington documents across multiple technologies and decades: Black bodies bear the experimental burden but are excluded from routine clinical benefit once devices become standard of care.(Washington, Harriet A., 2006)

The PolyHeme blood substitute trials of the early 2000s illustrate how emergency medicine settings compound this vulnerability. PolyHeme was tested on trauma victims without consent under FDA regulations permitting waived consent in emergency situations; Black Americans were enrolled at higher rates than their population share in the cities where trials operated.(Washington, Harriet A., 2006) FDA regulation 21 CFR 50.24, enacted in 1996, created this waiver provision; critics argued it established a systematic vulnerability that researchers could exploit by designing trials around emergency presentations, where Black and low-income trauma patients are disproportionately present.(Washington, Harriet A., 2006)

Harry Bailey’s deep sleep therapy experiments at Chelmsford Hospital, Australia, in the 1960s and 1970s used electrodes implanted in patients’ brains to induce prolonged sedation. Patients of color from low socioeconomic backgrounds were disproportionately enrolled; at least twenty-four patients died as a result of the procedures.(Washington, Harriet A., 2006)

The exclusionary half of the experimental pattern is equally well documented. Black Americans were systematically excluded from access to kidney dialysis and transplantation from the technologies’ inception. Even after the End-Stage Renal Disease program was enacted in 1972 to universalize dialysis access, Black patients received dialysis at lower rates and waited longer for transplants, despite having higher rates of kidney disease than white patients.(Washington, Harriet A., 2006)

Biological Warfare and State-Sponsored Experimentation

The most extreme applications of the logic that Black bodies were available for state use occurred in biological warfare research, where national security rationales provided institutional cover for non-consensual human experimentation in Black communities.

Operation MK-NAOMI, a CIA biological warfare program, released mosquitoes carrying yellow fever and other pathogens over Carver Village, a Black neighborhood in Pensacola, Florida, in 1956 and over Savannah, Georgia, in 1958. Residents had no knowledge of the releases; the purpose was to test the effectiveness of mosquito-borne pathogen dispersal over populated areas.(Washington, Harriet A., 2006) More broadly, U.S. military and intelligence agencies tested non-lethal biological agents on American civilians without consent from the 1950s through the 1970s; Black urban communities served as test sites for aerosol dispersal experiments in San Francisco, in New York subway tunnels, and in other cities, reflecting a pattern of treating minority neighborhoods as acceptable experimental zones.(Washington, Harriet A., 2006)

Declassified documents revealed that the Army’s Dugway Proving Ground conducted open-air releases of biological and chemical agents over populated areas of Utah and neighboring states. Communities of color near the proving ground received no warning and had no opportunity to take protective measures during or after these releases.(Washington, Harriet A., 2006)

Project SHAD (Shipboard Hazard and Defense) exposed thousands of U.S. military personnel to biological and chemical agents between 1963 and 1969. Black enlisted men were disproportionately represented among those exposed. Veterans were not informed of their exposure for decades, and the government denied the experiments existed until 2002, when declassified records forced acknowledgment.(Washington, Harriet A., 2006)

South Africa’s apartheid government ran Project Coast under Wouter Basson from 1981 to 1993, developing ethnic bioweapons designed to target Black Africans. Research included fertility-reducing agents, cholera deployment in water supplies, and anthrax weaponization. American scientists were documented as consultants to the program, raising questions about international complicity in apartheid biowarfare research.(Washington, Harriet A., 2006)

The threat of racially targeted biological weapons was not confined to the apartheid state. A 1997 Harper’s report documented that a Russian defector claimed the Soviet Union had engineered agents specifically targeting people of African descent based on genetic markers; U.S. defense analysts had investigated the feasibility of analogous programs.(Washington, Harriet A., 2006) Four of the five people killed in the 2001 anthrax letter attacks were Black, a pattern that researchers and advocates attributed partly to the racial demographics of mail-handling workers in the targeted cities.(Washington, Harriet A., 2006)

Washington argues that the entire pattern, from antebellum medical policing through Cold War biowarfare testing, constitutes a continuous history in which the bodies of African Americans were treated as disposable research material for purposes defined by state necessity, with no individual right to bodily autonomy permitted to interrupt that use. This pattern, she argues, has never been formally repudiated.(Washington, Harriet A., 2006)

Genomics and Surveillance

The genetics revolution introduced new experimental and surveillance risks for Black Americans. DNA fingerprinting exonerated numerous wrongfully convicted Black men in the 1990s but simultaneously enabled law enforcement to build racial databases; Black Americans were disproportionately represented in CODIS — the FBI’s DNA database — relative to their population share, raising Fourth Amendment concerns about permanent genetic surveillance of communities of color.(Washington, Harriet A., 2006) In 2002, police in Truro, Massachusetts pressured all adult men in a predominantly Black neighborhood to submit DNA samples to identify a murder suspect, creating a coercive de facto database with no sunset provision.(Washington, Harriet A., 2006) Forensic DNA phenotyping programs generating composite faces from genetic material were piloted primarily in high-crime Black neighborhoods, embedding racial profiling into ostensibly neutral technological tools and generating false-positive matches against Black civilians.(Washington, Harriet A., 2006) The A-HeFT trial supporting BiDil’s 2005 FDA approval enrolled only Black patients, meaning the drug was never tested comparatively across racial groups; researchers argued any apparent racial efficacy more likely reflected socioeconomic than biological differences, raising questions about whether race-based clinical trial design serves patients or pharmaceutical marketing.(Washington, Harriet A., 2006)

The Ethics Infrastructure as Reactive Response

The regulatory framework governing human subjects research was constructed after the abuses it was designed to prevent. The 1947 AEC policy first introduced the term “informed consent” in ethical policy, but it was not widely distributed and scientists routinely violated it.(Washington, Harriet A., 2006) The Office for Protection from Research Risks investigated abuses at over sixty research centers, including experiments that disproportionately enrolled African Americans and sometimes excluded whites by design.(Washington, Harriet A., 2006)

Experimental subjects in African American research were given vaccines with high lethality, enrolled without consent, subjected to covert surgeries, injected with toxins, deliberately left untreated, and secretly farmed for biological materials.(Washington, Harriet A., 2006) The Tuskegee Syphilis Study ran for twenty-five years after the Nuremberg Code was promulgated, demonstrating that the Code’s requirements, lacking enforcement mechanisms, were insufficient to protect subjects from institutional research programs with their own momentum.(Jonsen, 2000) Jackson’s overview concludes that the study raised “the more general question of the effectiveness of ethics codes as long as they are not sufficiently endorsed and enforced by legislation.”(Jackson (ed.), 2011)

The Department of Defense waived informed consent requirements for experimental anthrax vaccines and other investigational drugs administered to Gulf War troops in 1990 and 1991. Disproportionate rates of Gulf War illness among Black veterans subsequently raised questions about differential toxicity and inadequate health monitoring of minority soldiers.(Washington, Harriet A., 2006)

Washington identifies structural deficiencies in the post-Belmont system that persist despite its formal requirements. Institutional Review Boards have built-in conflicts of interest: the same institutions that profit from research also fund and staff the IRBs reviewing their protocols. Washington calls for independent IRBs with mandatory community representation from the populations most likely to be enrolled in any given research program.(Washington, Harriet A., 2006)

She also documents the phenomenon of “therapeutic misconception” as a consent problem with a racial dimension: research subjects frequently believe they are receiving personalized treatment when in fact they are enrolled in standardized trials. This misconception is disproportionately prevalent among Black patients, who are less likely to have access to equivalent care outside of a trial and thus conflate research participation with clinical access. The result is that the voluntariness required for valid informed consent is systematically undermined.(Washington, Harriet A., 2006)

African Americans’ medical distrust, documented across numerous studies as significantly higher than white Americans’, is in Washington’s analysis a rational adaptation to a documented history of harm rather than an irrational barrier to care. Treating distrust as a cultural competency problem to be managed through better communication misframes the issue. Addressing it requires structural reform of research ethics and healthcare access.(Washington, Harriet A., 2006)

Washington concludes that remedying what she terms “medical apartheid” requires measures commensurate with the scale of documented harm: not merely apology or symbolic acknowledgment but enforceable legal rights for research subjects, an independent national bioethics oversight body with subpoena power, mandatory health-impact assessments for research in minority communities, and reparative investment in Black community health infrastructure.(Washington, Harriet A., 2006)

[DISPUTED]

Contemporary clinical trials operate under IRB oversight, informed consent requirements, and the Belmont principles. Whether this framework is sufficient to prevent the structural exploitation of vulnerable populations, or whether it provides a procedural cover for continuing patterns of unequal risk distribution, is debated in bioethics scholarship. Washington’s argument is that the pattern persists in modified form; others argue that the post-Belmont regulatory framework represents a genuine transformation. The historical facts documented on this page are not seriously contested.

See Also

Sources

  • Washington, Harriet A. (2006). Medical Apartheid: The Dark History of Medical Experimentation on Black Americans from Colonial Times to the Present. Doubleday. (source_id: washington-medicalapartheid-2006)
  • Jonsen, Albert R. (2000). A Short History of Medical Ethics. Oxford University Press. (source_id: jonsen-short-history-medical-2000)
  • Jackson, Mark (ed.). (2011). The Oxford Handbook of the History of Medicine. Oxford University Press. (source_id: jackson-oxfordhandbook-2011)
  • Cooper Owens, Deirdre (2017). Medical Bondage: Race, Gender, and the Origins of American Gynecology. University of Georgia Press. (source_id: cooper-owens-medicalbondage-2017)

Editorial Notes

Sources

This article draws on 117 evidence cards from 5 sources.